Case report: Moderate therapeutic response to Bevacizumab in late-onset Labrune syndrome

Labrune syndrome (LS) is caused by SNORD118 gene mutations with a particular neuroimaging of white matter disease, intracranial calcification, and cysts. There was no effective treatment until now. An 18-year-old man with infancy-onset LS was first treated with vascular endothelial growth factor (VE...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Meiping, Lu, Jinmei, Wang, Xiaoxi, Ba, Xiaoqun, Wu, Dengchang, Zhang, Jianfang, Zhou, Jiajia, Wang, Kang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9552879/
https://www.ncbi.nlm.nih.gov/pubmed/36237624
http://dx.doi.org/10.3389/fneur.2022.968403

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9552879/
https://www.ncbi.nlm.nih.gov/pubmed/36237624
http://dx.doi.org/10.3389/fneur.2022.968403

Ejemplares similares